1
|
Hines L, Mali K, Campbell T, Jain R, Quarrier SO. Advancing Holmium Laser Enucleation of the Prostate Outcomes Reporting: An Assessment of Patient-Reported Outcomes in the Literature. Urology 2024:S0090-4295(24)00138-9. [PMID: 38442790 DOI: 10.1016/j.urology.2024.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 01/22/2024] [Accepted: 02/28/2024] [Indexed: 03/07/2024]
Abstract
Holmium laser enucleation of the prostate (HoLEP) is a size-independent option for benign prostatic hyperplasia surgical management. Since lower urinary tract symptoms (LUTS) are a quality-of-life issue, studies should prioritize patient-reported outcomes (PROs). This HoLEP review assesses PROs inclusion in the top 20 cited HoLEP studies and defines their limitations. PROs were categorized by domain: LUTS, incontinence, sexual function, pain, hematuria, and patient satisfaction. On review, no top-cited study included all PRO domains. The nuanced patient experience after HoLEP could be better defined via standardized utilization of validated PROs, while also improving comparability between HoLEP studies.
Collapse
Affiliation(s)
- Laena Hines
- Department of Urology, University of Rochester Medical Center, Rochester, NY.
| | - Kaela Mali
- University of Rochester School of Medicine and Dentistry, Rochester, NY
| | - Timothy Campbell
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Rajat Jain
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Scott O Quarrier
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| |
Collapse
|
2
|
Chait AR, Hassig S, Cubillos J, Jain R, Quarrier SO. Cystinuria Complicated by Anuria From Bilateral Obstructing Stones Requiring Bilateral Mini Percutaneous Nephrolithotomy in a 22-Month-Old. Urology 2024; 185:88-90. [PMID: 38281667 DOI: 10.1016/j.urology.2023.12.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Accepted: 12/31/2023] [Indexed: 01/30/2024]
Abstract
Pediatric nephrolithiasis is increasing in incidence and presents differently compared to adults. We report a case of nephrolithiasis in a pediatric patient, presenting with complaints of emesis, anuria, hematuria, and abdominal distension, leading to a diagnosis of bilateral obstructing cystine stones requiring bilateral percutaneous nephrolithotomy. Pediatric patients with anuria should be evaluated for bilateral nephrolithiasis as an etiology. Calculous anuria requires prompt recognition of the pathologic process and relief of the obstruction with close follow-up and supportive care until definitive stone management. Bilateral percutaneous nephrolithotomy can provide definitive surgical intervention without significant morbidity.
Collapse
Affiliation(s)
- Alexander R Chait
- Department of Urology, University of Rochester Medical Center, Rochester, NY.
| | - Stephen Hassig
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Jimena Cubillos
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Rajat Jain
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Scott O Quarrier
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| |
Collapse
|
3
|
Song DY, Ceraolo CA, Doersch KM, Campbell TD, Wanderling C, Schuler N, Jain RK, Quarrier SO. Neighborhood Social Vulnerability Impacts Quality of Life in Kidney Stone Patients. Urol Pract 2024; 11:180-184. [PMID: 37902693 DOI: 10.1097/upj.0000000000000468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Accepted: 09/21/2023] [Indexed: 10/31/2023]
Abstract
INTRODUCTION This study aimed to investigate the association between social vulnerability, as measured by the Centers for Disease Control and Prevention's Social Vulnerability Index (SVI), and the quality of life (QoL) of kidney stone patients using the validated Wisconsin Stone Quality of Life Questionnaire (WISQOL). METHODS A retrospective analysis was conducted on medical records of new urolithiasis patients who completed the WISQOL at the University of Rochester Medical Center kidney stone clinic. The primary outcome was WISQOL score, which was measured across multiple domains. SVI was used to assess social vulnerability. Neighborhoods with high SVI were defined by a threshold greater than or equal to the 75th percentile nationally. Demographic and clinical data were collected. Statistical analyses, including univariate tests and multivariate linear regression, were performed to evaluate the relationships between social vulnerability and disease-specific QoL. RESULTS A total of 1718 patients were included in the study. One hundred five subjects (6.1%) were from neighborhoods of high social vulnerability. Patients residing in neighborhoods with high social vulnerability (SVI quartile) reported significantly lower QoL scores (69.1 vs 77.2; P = .001) and this persisted across all domains, including social impact (32.6 vs 35.1; P = .002), emotional impact (25.2 vs 27.5; P = .006), disease impact (28.5 vs 31.4; P = .001), and vitality (10.3 vs 11.2; P = .015). Younger age, female sex, and higher number of comorbidities were identified as independent predictors of lower QoL scores. However, non-White race and Latinx ethnicity did not exhibit a significant association with QoL scores. CONCLUSIONS These findings highlight the negative impact of high social vulnerability on QoL, emphasizing the importance of considering socioeconomic factors in patient care. These results emphasize the need for targeted interventions to support vulnerable populations. While this study offers initial insights, further research is essential to corroborate these outcomes across larger and more diverse populations.
Collapse
Affiliation(s)
- David Y Song
- University of Rochester Medical Center, Rochester, New York
| | - Carl A Ceraolo
- University of Rochester Medical Center, Rochester, New York
| | | | | | | | - Nathan Schuler
- University of Rochester Medical Center, Rochester, New York
| | - Rajat K Jain
- University of Rochester Medical Center, Rochester, New York
| | | |
Collapse
|
4
|
Lee AJ, Campbell T, Ceraolo CA, Saxton A, Quarrier SO, Bandari J. The Changing Roles of Urologists, Radiologists, and Advanced Practice Providers in Uroradiology Procedures. Urol Pract 2024; 11:228-235. [PMID: 37903750 DOI: 10.1097/upj.0000000000000482] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Accepted: 10/13/2023] [Indexed: 11/01/2023]
Abstract
INTRODUCTION Urology has seen shifts in the management of many urologic conditions with the advent of noninvasive procedures that rely on multidisciplinary radiological modalities. This study seeks to analyze changes in urologists, radiologists, and advanced practice providers (APPs) performing uroradiology procedures over time. METHODS The Centers for Medicare & Medicaid Services Physician/Procedure Summary data from 2010 to 2021 were utilized to examine uroradiology Current Procedural Terminology codes billed by urologists, radiologists, and APPs. Percent of total reimbursement and higher volume procedure count (after excluding providers with <11 procedures by per year) by each provider field was calculated and analyzed for changes in distribution from 2010 to 2021. RESULTS There were significant changes in all procedures when examining procedure reimbursement distribution in 2010 to 2021 (P < .001). During the period, urology saw decreases in reimbursement proportion as large as 28.7% for kidney cryoablation and increases as large as 14.2% for nephrostomy tube removals. Radiology saw the largest decreases in reimbursement proportion with an 18.9% decrease for nephrostograms, while the largest increase was 23.6% for suprapubic tube placements. APPs saw the largest increase in suprapubic tube changes reimbursement proportion, which rose 14.2% from 2010 to 2021. There were significant changes in proportion in all procedures, except for antegrade stent, renal cryoablation, renal biopsy, and renal thermoablation. CONCLUSIONS Uroradiology procedures have seen shifts in the distribution of which provider type performs each procedure. Most large changes in reimbursement and procedure proportion were shifted between urology and radiology, with APPs seeing smaller changes.
Collapse
Affiliation(s)
- Austin J Lee
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| | - Timothy Campbell
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| | - Carl A Ceraolo
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| | - Aaron Saxton
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| | - Scott O Quarrier
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| | - Jathin Bandari
- Department of Urology, University of Rochester Medical Center, Rochester, New York
| |
Collapse
|
5
|
Hines L, Doersch KM, Ninomiya M, Jain R, Quarrier SO. Redefining Clinically Significant Hematuria After Holmium Enucleation of the Prostate. J Endourol 2023; 37:1216-1220. [PMID: 37725558 DOI: 10.1089/end.2023.0317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/21/2023] Open
Abstract
Introduction and Objective: Holmium laser enucleation of the prostate (HoLEP) is often offered for symptomatic prostatic enlargement at high risk for bleeding. However, prior studies define clinically significant hematuria (CSH) narrowly as the need for blood transfusion or significant decrease in hemoglobin. We sought to evaluate risk factors contributing to a broader definition of CSH, which may contribute to alteration of clinical course. Methods: We analyzed 164 patients in a prospectively maintained database who underwent HoLEP at a single institution across two surgeons from November 2020 to April 2023. HoLEP was performed using Moses 2.0 (Boston Scientific) laser and the Piranha enucleation system (Richard Wolf). We defined CSH broadly as follows: clot retention, return to operating room, perioperative management variation due to hematuria, or continued gross hematuria past 1 month postoperatively. Univariable and multivariable ANOVAs were used. Multivariable analysis of CSH risk based on the use of antiplatelet (AP) agents or anticoagulants included correction for age, enucleation time (surrogate for case difficulty), and prostate volume. Results: 17.7% (29/164) of our patients developed CSH after HoLEP. Longer enucleation time was a mild risk factor for developing CSH (multivariate odds ratio [OR] 1.01, p = 0.02). The strongest predictor of CSH was the use of anticoagulation or AP agents (OR 2.71 p < 0.02 on univariable analysis, OR 2.34 p < 0.02 on multivariable analysis), even when aspirin 81 mg was excluded. Conclusion: With a broadened definition, 18% of patients developed CSH following HoLEP, which impacted the clinical course. Our data suggest that the current definition of significant hematuria is too narrow and does not capture many patients whose clinical course is affected by hematuria. While safe, anticoagulants and APs significantly predicted an increased CSH risk, and patients should be counseled accordingly.
Collapse
Affiliation(s)
- Laena Hines
- Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
| | - Karen M Doersch
- Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
| | - Mark Ninomiya
- University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
| | - Rajat Jain
- Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
| | - Scott O Quarrier
- Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
| |
Collapse
|
6
|
Phan D, Saxton A, Rabinowitz R, Quarrier SO. Testicular Compartment Syndrome After Trauma Managed With a Tunica Vaginalis Flap. Urology 2023; 176:175-177. [PMID: 36822244 DOI: 10.1016/j.urology.2023.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Revised: 01/25/2023] [Accepted: 02/05/2023] [Indexed: 02/23/2023]
Abstract
Testicular compartment syndrome requires timely diagnosis and intervention but may be challenging. We present a case discussing the presentation and management of testicular compartment syndrome following testicular trauma in an 11-year-old male. The patient presented 24 hours after testicular trauma from a kick with testicular enlargement and sharp pain. Ultrasound showed markedly decreased blood flow and a reactive hydrocele. Testis-sparing intervention included emergent tunica albuginea incision, debridement, and tunica vaginalis flap.
Collapse
Affiliation(s)
- Dennis Phan
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Aaron Saxton
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Ronald Rabinowitz
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Scott O Quarrier
- Department of Urology, University of Rochester Medical Center, Rochester, NY.
| |
Collapse
|
7
|
Gochenaur L, Osinski T, Wanderling C, Quarrier SO. A case report of a proximal corporal cavernosa injury presenting with butterfly perineal ecchymosis. Urol Case Rep 2021; 40:101870. [PMID: 34646742 PMCID: PMC8497844 DOI: 10.1016/j.eucr.2021.101870] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 09/18/2021] [Accepted: 09/27/2021] [Indexed: 11/18/2022] Open
Abstract
This is a case of a proximal corpus cavernosa fracture presenting with scrotal edema and butterfly perineal ecchymosis sparing the penile shaft. Preoperative MRI obviated the need for circumferential incision and degloving of the penis and guided immediate incision over the area of corporal injury. The presentation, diagnostic work-up, and surgical treatment are discussed.
Collapse
|
8
|
Quarrier SO, Matloubieh JE, Wu G. Robot-assisted Placement of Pelvic Tissue Expander for Radiation After Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence. Urology 2018; 124:292-296. [PMID: 30385261 DOI: 10.1016/j.urology.2018.09.027] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2018] [Revised: 08/20/2018] [Accepted: 09/24/2018] [Indexed: 10/28/2022]
Abstract
OBJECTIVE To present a robot-assisted surgical technique for overcoming challenges of a patient with prior pelvic surgeries and bowel in the radiation target. METHODS A 72-year-old male required treatment for biochemically recurrent prostate cancer. In 2006, he presented with Prostate-Specific Antigen (PSA) 5.74 ng/mL, Gleason 3 + 3 prostate cancer. He underwent a robot-assisted radical prostatectomy for pT2aNx adenocarcinoma with negative margins. In 2008, he was found to have muscle-invasive high-grade papillary urothelial carcinoma and underwent robot-assisted radical cystectomy and ileal conduit for pT2bN0 urothelial carcinoma. In 2017, he had prostate cancer biochemical recurrence, with a PSA of 0.27 ng/mL. Pelvic CT showed small bowel in his prostatic bed behind the pubic bone. A robot-assisted lysis of adhesions and placement of a tissue expander in the prostatic fossa was performed. Three robotic ports and 1 assistant port were utilized. The sigmoid and small bowel were displaced during lysis of adhesions. The deflated tissue expander was inserted through the midline trocar site, inflated intra-abdominally, and filled with 330 cc of saline. The tissue expander was secured with proline sutures in a dependent position. The patient subsequently underwent Intensity-modulated radiation therapy of 66 Gy to the prostatic fossa. Eleven days after finishing intensity-modulated radiation therapy, he underwent successful laparoscopic removal of the tissue expander. PSA nadir was <0.02 ng/mL. RESULTS The patient tolerated intensity-modulated radiation therapy without complications. There were no gastrointestinal complaints following radiation therapy. CONCLUSION Robotic placement of a tissue expander in patients who have undergone multiple pelvic surgeries is feasible and may reduce radiation morbidity.
Collapse
Affiliation(s)
- Scott O Quarrier
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Jubin E Matloubieh
- Department of Urology, University of Rochester Medical Center, Rochester, NY
| | - Guan Wu
- Department of Urology, University of Rochester Medical Center, Rochester, NY.
| |
Collapse
|